VRTX · Vertex Pharmaceuticals Inc · Documents
$523.93
-11.24 (-2.10%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$132.80B
Shares
253.46M
Volume · Oct 23
833.46K
Avg daily vol (3M)
1.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2021-07-30 | 2021-06-30 | |
| 8-K | — | 2021-07-29 | — | |
| 8-K | — | 2021-06-24 | 2021-06-23 | |
| 8-K | — | 2021-05-19 | — | |
| 10-Q | — | 2021-04-30 | 2021-03-31 | |
| 8-K | — | 2021-04-29 | — | |
| 8-K | — | 2021-04-20 | 2021-04-16 | |
| DEF 14A | — | 2021-04-08 | 2021-05-19 | |
| DEFA14A | — | 2021-04-08 | — | |
| 10-K | — | 2021-02-11 | 2020-12-31 | |
| 8-K | — | 2021-02-01 | — | |
| 8-K | — | 2020-11-20 | — | |
| 10-Q | — | 2020-10-30 | 2020-09-30 | |
| 8-K | — | 2020-10-29 | — | |
| 8-K | — | 2020-09-21 | 2020-09-18 | |
| 10-Q | — | 2020-07-31 | 2020-06-30 | |
| 8-K | — | 2020-07-30 | — | |
| 8-K | — | 2020-06-03 | — | |
| 10-Q | — | 2020-05-01 | 2020-03-31 | |
| 8-K | — | 2020-04-29 | — | |
| DEF 14A | — | 2020-04-28 | 2020-06-03 | |
| DEFA14A | — | 2020-04-28 | — | |
| DEFA14A | — | 2020-04-28 | — | |
| 8-K | — | 2020-04-01 | — | |
| 10-K | — | 2020-02-13 | 2019-12-31 | |
| 8-K | — | 2020-01-30 | — |
Showing 101–126 of 126 filings
Key facts
CIK
875320
CUSIP
92532F100
13F (30d)
506 filings
484 filers
Visit website
Investor relations